Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

Related Articles by Review for PubMed (Select 22381431)

1.

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.

Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, Matsushita N, Blusztajn A, Terrovitis J, Kusuoka H, Marbán L, Marbán E.

J Am Coll Cardiol. 2012 Mar 6;59(10):942-53. doi: 10.1016/j.jacc.2011.11.029.

2.

Cardiac differentiation and electrophysiology characteristics of bone marrow mesenchymal stem cells.

Liu BW, Lü AL, Hou J, Huang W, Li Y, Hou ZL, Hou H, Da J, Yang N, Ai SY.

Chin Med J (Engl). 2012 Sep;125(18):3318-24. Review.

PMID:
22964330
3.

Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.

Wen Z, Zheng S, Zhou C, Yuan W, Wang J, Wang T.

J Cell Mol Med. 2012 Apr;16(4):657-71. doi: 10.1111/j.1582-4934.2011.01471.x. Review.

4.

[Research progresses of paracrine effect of bone marrow derived mesenchymal stem cells on wound healing].

Luo Q, Zhang C, Song G.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2012 Oct;29(5):999-1002. Review. Chinese.

PMID:
23198449
5.

"String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results.

Keith MC, Bolli R.

Circ Res. 2015 Mar 27;116(7):1216-30. doi: 10.1161/CIRCRESAHA.116.305557. Review.

PMID:
25814683
6.

Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel.

Smith RR, Marbán E, Marbán L.

Biomatter. 2013 Jan-Mar;3(1). pii: e24490. doi: 10.4161/biom.24490. Epub 2013 Jan 1. Review.

7.

Cardiosphere-derived progenitor cells for myocardial repair following myocardial infarction.

Sousonis V, Nanas J, Terrovitis J.

Curr Pharm Des. 2014;20(12):2003-11. Review.

PMID:
23844734
8.

Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.

Wen Z, Zheng S, Zhou C, Wang J, Wang T.

J Cell Mol Med. 2011 May;15(5):1032-43. doi: 10.1111/j.1582-4934.2010.01255.x. Review.

9.

Cardiac stem cell therapy: review of the native cardiac progenitor cells and future direction.

Ye J, Yeghiazarians Y.

J Cardiovasc Pharmacol. 2014 Feb;63(2):85-94. doi: 10.1097/FJC.0b013e318299ebc0. Review.

PMID:
23674056
10.

Mesenchymal stem cell insights: prospects in cardiovascular therapy.

Chou SH, Lin SZ, Kuo WW, Pai P, Lin JY, Lai CH, Kuo CH, Lin KH, Tsai FJ, Huang CY.

Cell Transplant. 2014;23(4-5):513-29. doi: 10.3727/096368914X678436. Review.

PMID:
24816448
11.

Resident cardiac stem cells and their role in stem cell therapies for myocardial repair.

Mayfield AE, Tilokee EL, Davis DR.

Can J Cardiol. 2014 Nov;30(11):1288-98. doi: 10.1016/j.cjca.2014.03.018. Epub 2014 Mar 20. Review.

PMID:
25092406
12.

Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research.

Zhang H, Wang H, Li N, Duan CE, Yang YJ.

Heart Fail Rev. 2014 Mar;19(2):247-58. doi: 10.1007/s10741-013-9372-0. Review.

PMID:
23381197
13.

Paracrine mechanisms of stem cell reparative and regenerative actions in the heart.

Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ.

J Mol Cell Cardiol. 2011 Feb;50(2):280-9. doi: 10.1016/j.yjmcc.2010.08.005. Epub 2010 Aug 19. Review.

14.

Genetic modification of stem cells for improved therapy of the infarcted myocardium.

Haider HKh, Mustafa A, Feng Y, Ashraf M.

Mol Pharm. 2011 Oct 3;8(5):1446-57. doi: 10.1021/mp2001318. Epub 2011 Jun 8. Review.

PMID:
21591779
15.

Paracrine effects of stem cells in wound healing and cancer progression (Review).

Dittmer J, Leyh B.

Int J Oncol. 2014 Jun;44(6):1789-98. doi: 10.3892/ijo.2014.2385. Epub 2014 Apr 11. Review.

16.

Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury.

Khubutiya MS, Vagabov AV, Temnov AA, Sklifas AN.

Cytotherapy. 2014 May;16(5):579-85. doi: 10.1016/j.jcyt.2013.07.017. Epub 2013 Oct 8. Review.

PMID:
24113425
17.

Human cardiomyocyte progenitor cells: a short history of nearly everything.

van Vliet P, Goumans MJ, Doevendans PA, Sluijter JP.

J Cell Mol Med. 2012 Aug;16(8):1669-73. doi: 10.1111/j.1582-4934.2012.01535.x. Review.

18.

Age-associated changes in the ecological niche: implications for mesenchymal stem cell aging.

Asumda FZ.

Stem Cell Res Ther. 2013 May 14;4(3):47. doi: 10.1186/scrt197. Review.

19.

Heart regeneration, stem cells, and cytokines.

Li N, Wang C, Jia L, Du J.

Regen Med Res. 2014 Apr 2;2(1):6. doi: 10.1186/2050-490X-2-6. eCollection 2014 Dec. Review.

20.

Multipotent stem cells of the heart-do they have therapeutic promise?

Leite CF, Almeida TR, Lopes CS, Dias da Silva VJ.

Front Physiol. 2015 May 8;6:123. doi: 10.3389/fphys.2015.00123. eCollection 2015. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk